[ad_1]
What happened
<p class = "canvas-atom-canvas-text Mb (1.0em) Mb (0) – sm Mt (0.8em) – sm" type = "text" content = "Actions of Johnson & amp; Johnson (NYSE: JNJ) closed Friday at 4.15% after Bloomberg & nbsp; announced that the US Department of Justice (DOJ) was investigating the health conglomerate to find out if the company had lied about the possible cancer risks associated with its talc. Johnson & Johnson (NYSE: JNJ) Bloomberg ended Friday at 4.15% after Bloomberg announced that the US Department of Justice was investigating the health care conglomerate to determine whether the company had lied about the potential cancer risks associated with its talcum powder.
So what
<p class = "canvas-atom canvas-text Mb (1.0em) Mb (0) – sm Mt (0.8em) – sm" type = "text" content = "Bloomberg quoted unnamed sources, but it seems likely that the report of the investigation is real – unlike press reports of potential mergers by anonymous sources, which sometimes come to fruition. "data-reactid =" 14 "> Bloomberg cited unnamed sources, but it seems likely that the report of the investigation is real – in contrast to press reports of potential mergers by unnamed sources, which sometimes only materialize from time to time.
<p class = "canvas-atom web-text Mb (1.0em) Mb (0) – sm Mt (0.8em) – sm" type = "text" content = "The news adds to the seemingly endless saga The year claimants were awarded $ 4.69 billion for allegedly causing ovarian cancer, and in December Reuters announced that Johnson & Johnson knew data-reaid = "15"> This new addition to the seemingly endless saga of Johnson & Johnson's talc-based products. Last year, the plaintiffs won a $ 4.69 billion ovarian cancer award and in December, Reuters reported that Johnson & Johnson had known for decades that its talc products contained l & # 39; asbestos.
Johnson & Johnson said in February that the GM and others had asked questions about talc products, but the disclosure was quite brief: "The company has received preliminary investigations and subpoenas to produce documents on this subject from Senator Murray, member of the Senate Committee on Health, Education, Labor and Retirement, the Department of Justice and the Securities and Exchange Commission. "
Bloomberg asserts that the DOJ's investigation is a criminal investigation and that a grand jury reviews documents related to allegations that company officials were aware of the existence of agents carcinogenic in products.
In front of a courthouse.
Source of the image: Getty Images.
Now what
Johnson & Johnson is expected to release its results for the second quarter on Tuesday, but it seems likely that the company will not comment on the investigation if it is to say that it is cooperating with companies. officials.
Although a criminal investigation will weigh down the fire, investors should monitor more than 14,000 civil suits, which will likely be a bigger financial problem for Johnson & Johnson.
<p class = "canvas-atom canvas-text Mb (1.0em) Mb (0) – sm Mt (0.8em) – sm" type = "text" content = " More from The Motley Fool "data-reactid =" 33 "> More from The Motley Fool
<p class = "canvas-atom canvas-text Mb (1.0em) Mb (0) – sm Mt (0.8em) – sm" type = "text" content = "Brian Orelli has no position in any of the actions mentioned. The Motley Fool recommends Johnson & amp; Johnson. The Motley Fool has a disclosure policy."data-reactid =" 41 ">Brian Orelli does not own any of the shares mentioned. The Motley Fool recommends Johnson & Johnson. Motley Fool has a disclosure policy.
[ad_2]
Source link